Skip to main content
. 2023 Feb 8;9(1):20552173221144229. doi: 10.1177/20552173221144229

Table 1.

Demographic and other baseline characteristics of patients.

DMF
(N=177)		 Interferon
(N=46)
Sex, N (%)
Males
Females		 n=176
57 (32.4%)
119 (67.6%)		 n=45
16 (35.6%)
29 (64.4%)
Age, years
Mean + SD
Median (range)		 n=176
35.7 + 10.3
35.0 (18–61)		 n=45
37.4 + 12.7
34.0 (19–68)
BMI, kg/m2
Mean + SD
Median (range)		 n=153
24.3 + 4.2
23.4 (16–36)		 n=41
24.2 + 5.1
23.0 (18–41)
Time from first RRMS diagnosis, days
Mean + SD
Median (range)		 n=176
236.2 + 411.1
65.5 (0–2537)		 n=46
216.6 + 427.3
52.0 (19–1927)
EDSS score
Mean + SD
Median (range)		 n=176
1.6 + 1.1
1.5 (0–5)		 n=45
1.6 + 0.9
1.5 (0–4)
PSQI score
Mean + SD
Median (range)		 n=165
6.0 + 3.7
5.0 (0–18)		 n=41
5.8 + 3.3
6.0 (1–13)

N: number of patients; n: number of observations; DMF: dimethyl fumarate; RRMS: relapsing-remitting multiple sclerosis; PSQI: Pittsburgh Sleep Quality Index; BMI: body mass index.